My cost basis is around $5 (around 12k shares). It's only this low because I have bought on the way down. Not saying this is the right strategy, but I did buy more the past week. Once at 1.35 and today @ 1.12. Only about 1,500 shares total.
January will be very telling. I'm expecting EVU announcement to coincide with JPM conference. It sounds like they planned EVU news before EOY, but didn't want to get lost in tax selling, etc. If we don't get it in the first week or two (on or before JPM) I will be concerned.
At least 2019 is here. If we do not get at minimum design freeze and FDA sub this year I'm probably out. As much as MC screwed up royally on lying about supporting pps after reverse and raise, he has laid the foundation for success for Titan (IP, Clinical, etc.). If we complete the stated milestones we should be golden. This includes absorbing another raise (short term pain).
Bottom line, this is the year we know if we move to the final stage. Mc & Co. have stated unequivocally that design freeze, FDA, etc are happening this year. Any diversion from this and its a fire sale. Good luck staying afloat and raising @ .30. I'm still confident they will get it done despite this entire sh**show of an investment. There is light at the end of the tunnel. We can finally move on either way.
Lastly, we need more of BigT on here (positivity for a change) . If you buy or sell based on this board and not your own DD then that's on you. It's clear he does extensive DD and offers his opinion. The foundation he lays out is usually right on, just doesn't always work out. Just cause we've tanked does that mean Skaarg is a genius???
GLTA
